Meimei Lin

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Mesenchymal Stem Cells

Systematic Review

Top Venues

Hepatology communications

JMIR mHealth and uHealth

Journal of clinical and translational hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Hengfen Dai, Jing Yang
Development and Validation of a Clinical Risk Score to Predict Immune-mediated Liver Injury Caused by Sintilimab: Assessed for Causality Using Updated RUCAM. Journal of clinical and translational hepatology 11 (6) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)
Caiyun Zheng, Shunmin Huang, Meimei Lin, Baohui Hong, Ruping Ni, Hengfen Dai, Xiuqin Lin, Jing Yang
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known. Hepatology communications 7 (3) (2023)
Caiyun Zheng, Xu Chen, Lizhu Weng, Ling Guo, Haiting Xu, Meimei Lin, Yan Xue, Xiuqin Lin, Aiqin Yang, Lili Yu, Zenggui Xue, Jing Yang
Benefits of Mobile Apps for Cancer Pain Management: Systematic Review. JMIR mHealth and uHealth 8 (1) (2020)